Preoperative BRAF inhibition in patients with irresectable locally advanced stage III melanoma
Aim: Neoadjuvant treatment of locally advanced disease with BRAF inhibitors is expected to increase the likelihood of a R0 resection. We present six patients with stage III unresectable melanoma, neoadjuvantly treated with BRAF inhibitors. Methods: Patients with unresectable, BRAF-mutated, stage III...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis Group
2018-06-01
|
| Saila: | Melanoma Management |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.futuremedicine.com/doi/10.2217/mmt-2018-0002 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|